Log In

Status Information

Status
DISCOURAGED

Term Description

Female participants are asked whether they have ever used Evista® or Nolvadex® and then asked length of time they used it as well as whether they are currently using it. They are asked whether they are using any over-the-counter preparations for hormone replacement or post-menopause symptoms. Lastly, they are asked about their use of prescription female hormones (number of months taken, types, dosage). Note: PhenX staff removed embedded dates of original study for clarity of Toolkit users.

Reference Information

TypeSourceReference
CitationConsensus measures for Phenotypes and ExposuresHarvard Medical School. Nurses Health Study II, 2009. Boston, MA. Question numbers 8-10.
ArticleConsensus measures for Phenotypes and ExposuresTownsend MK, Curhan GC, Resnick NM, Grodstein F. (2009). Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women. Am J Obstet Gynecol, 200(1):86.e1-5. Epub 2008 Nov 18. PubMed PMID: 19019333, PubMed Central PMCID: PMC2637519.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
62660-6PhenX - hormonal therapy protocol 100701
Indent64645-5Have you used Evista® (raloxifene) or Nolvadex® (tamoxifen)?
Indent64646-3How many months have you used Evista®?mo
Indent64647-1How many months have you used Nolvadex®?mo
Indent64648-9Are you currently using Evista® or Nolvadex®?
Indent64649-7Are you currently using any over-the-counter (e.g., "herbal," "natural," or soy-based) preparations for hormone replacement or to treat post-menopausal symptoms?
Indent64650-5What types?
Indent64651-3Have you used prescription female hormones?
Indent64652-1How many months did you use hormones?mo
Indent64653-9Are you currently using them (within the last month)?
Indent64654-7Mark the type(s) of hormones you are CURRENTLY using: Combined.
Indent64655-4Mark the type(s) of hormones you are CURRENTLY using: Estrogen.
Indent64656-2Please specify Other Estrogen you are CURRENTLY using.
Indent64657-0Mark the type(s) of hormones you are CURRENTLY using: Progesterone/Progestin.
Indent64658-8Please specify Other progresterone you are CURRENTLY using
Indent64659-6Other hormones CURRENTLY used (e.g., Tri-est).
Indent64660-4If you used oral conjugated estrogen (e.g., Premarin®), what dose did you usually take?
Indent64661-2What was your pattern of hormone use (Days per Month)? Estrogen.
Indent64662-0What was your pattern of hormone use (Days per Month)? Progesterone.

LOINC Names Get Info

Fully-Specified Name
PhenX - hormonal therapy protocol 100701:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - hormonal therapy protocol 100701
Short Name
Hormonal therapy proto

Part Model Get Info

  • Component
    PhenX - hormonal therapy protocol 100701
    LP111944-7
    • Analyte
      PhenX - hormonal therapy protocol 100701
      LP111944-7
      • Component Numerator
        PhenX - hormonal therapy protocol 100701
        LP111944-7
        • Component Numerator Core
          PhenX - hormonal therapy protocol 100701
          LP111944-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Survey Question

PX100701

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.81 (MIN)
Change Reason
Release 2.81: Status: Changing concept status from Trial to Discouraged upon recommendation from RTI; concept is deprecated in PhenX toolkit; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
62642-4PhenX domain - Reproductive health

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - ορμονοθεραπεία πρωτόκολλο 100701:-:Pt:^Ασθενής:-:PhenX
Synonyms: - PANEL.PHENX PHENX PhenX - ορμονοθεραπεία πρωτόκολλο 100701 Pt Ασθενής
es-MXSpanish (Mexico)PhenX - protocolo de terapia hormonal 100701:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - terapia ormonale, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RURussian (Russian Federation)PhenX - гормональная терапия протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: Точка во времени;Момент
zh-CNChinese (China)PhenX - 激素治疗方案 100701:-:时间点:^患者:-:PhenX
Synonyms: Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 PhenX - 激素疗法方案 100701;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62660-6
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62660-6